Q3 2020 Novozymes A/S Earnings Call Transcript
/-
Thank you, operator, and welcome, everyone. Thank you for joining us. My name is Tobias Bjorklund, and I'm the Head of Investor Relations at Novozymes.
At this call, Ester Baiget, CEO of Novozymes; and Lars Green, our CFO, will go through our performance for the first 9 months of 2020, the outlook for the full year and comment on the recent changes to our organizational setup. We expect the presentation to take roughly 20 minutes. After which, we will open up for questions.
Also with us today, we have the rest of the management team, namely: Anders Lund, EVP Consumer Biosolutions; Tina Fanø, EVP Industrial Biosolutions; Thomas Videbaek, Interim EVP of Strategy and Business Transformation as well as People, Sustainability and Brand; Claus Fuglsang, Chief Science Officer; and Graziela Malucelli, Chief of Operations. We expect the entire call to take 50 minutes.
Before we begin, I would like to remind you that the information presented at the call is unaudited and that management may make
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |